Evidence map›Paper›PMID 35622926›Full record

ArticleScience advances2022

Chemodivergent Csp

Kaluvu Balaraman, Christian Wolf

Abstract read
In one paragraph

Article in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kaluvu BalaramanDepartment of Chemistry, Georgetown University, Washington, DC 20057, USA.ORCID 0000-0003-2020-269X
Christian WolfDepartment of Chemistry, Georgetown University, Washington, DC 20057, USA.ORCID 0000-0002-4447-3753

Funding

Synthesis of Chiral Organofluorines via Catalytic Asymmetric C-C Bond Formation wR15GM106260 · NIGMS · GEORGETOWN UNIVERSITY · PI Christian Wolf · 2013 to 2026
$2.2M
NIGMS NIH HHS R15 GM106260
6 · The paper itself

Abstract

The widespread use of fluorinated organic compounds in the health, agrochemical, and materials sciences is sustained by a steadily growing pool of commercially available fine chemicals. The synthetic utility of the increasingly ubiquitous Csp

Identifiers

PMID35622926
PMCPMC9140971

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.